The diagnosis of HCC can often be made using non-invasive imaging such as ultrasonography, computed tomography (CT), and magnetic resonance tomography (MRI), aided by the use of LiRADS criteria, along with the measurement of alpha-fetoprotein (AFP) level, a predictive biomarker for HCC (8). Here, AFP is linked to hepatocellular carcinoma.